What is micronized progesterone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Micronized Progesterone: Clinical Applications and Benefits

Micronized progesterone is a bioidentical form of progesterone that is chemically identical to the natural hormone produced by the ovaries, processed into tiny particles to improve oral absorption and bioavailability. Natural micronized progesterone has a more favorable safety profile compared to synthetic progestogens, particularly regarding cardiovascular effects, thrombotic risk, and breast tissue effects. 1

Pharmacology and Formulation

  • Micronized progesterone is available in oral capsules (100mg and 200mg) and vaginal gel formulations 2
  • The micronization process increases bioavailability by reducing particle size
  • Maximum serum concentrations are achieved within 3 hours of oral administration 2
  • Bioavailability is increased when taken with food 2
  • Contains peanut oil as an inactive ingredient in many oral formulations (important contraindication for patients with severe peanut allergies) 1, 2

Clinical Applications

Hormone Replacement Therapy (HRT)

Micronized progesterone is a preferred option for HRT in women with intact uterus:

  • Protects the endometrium from hyperplasia when combined with estrogen 1, 3
  • Recommended dosing:
    • 200 mg orally for 12-14 days per month in sequential regimens 4
    • 100 mg daily for continuous regimens 5
  • European Society for Human Reproduction and Embryology (ESHRE) includes micronized progesterone among recommended progestogens for HRT in women with ovarian insufficiency due to its safer pharmacological profile 1

Premature Ovarian Insufficiency (POI)

For women with POI, micronized progesterone offers:

  • Lower cardiovascular risk compared to synthetic progestogens 1
  • Neutral or beneficial effect on blood pressure 1
  • Better safety profile regarding thrombotic risk 1
  • Dosing for adolescents with POI: Begin with 100-200 mg/day during 12-14 days of the month after 2 years of estrogen therapy or when breakthrough bleeding occurs 1

Advantages Over Synthetic Progestogens

  1. Cardiovascular effects:

    • Minimizes hormone-related cardiovascular risks 1
    • Neutral or beneficial effect on blood pressure 1
  2. Thrombotic risk:

    • One of the best safety profiles regarding thrombotic risk 1
  3. Breast tissue effects:

    • Does not increase cell proliferation in breast tissue (unlike synthetic progestogens like medroxyprogesterone acetate) 3
    • May be associated with lower breast cancer risk compared to synthetic progestogens 3
  4. Metabolic effects:

    • Less negative impact on lipid metabolism compared to synthetic progestogens 1
    • Less androgenic effects 1

Side Effects and Contraindications

  • Main side effect: mild and transient drowsiness (minimized by taking at bedtime) 5
  • Contraindications:
    • Severe peanut allergies (for formulations containing peanut oil) 1, 2
    • Hormone receptor-positive breast cancer 1
    • Active liver disease 4
    • History of venous thromboembolism or stroke 4

Clinical Pearls

  • For optimal absorption, oral micronized progesterone should be taken with food 2
  • Vaginal gel formulations are available for patients with peanut allergies 1
  • When used for HRT, micronized progesterone should be combined with estrogen in women with an intact uterus to prevent endometrial hyperplasia 4, 3
  • The Postmenopausal Estrogen/Progestin Intervention trial recommended oral micronized progesterone as the first choice for opposing estrogen therapy in non-hysterectomized postmenopausal women 5

Micronized progesterone represents an important advancement in hormone therapy, offering the benefits of natural progesterone with improved bioavailability and a favorable safety profile compared to synthetic alternatives.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Micronized progesterone and its impact on the endometrium and breast vs. progestogens.

Climacteric : the journal of the International Menopause Society, 2012

Guideline

Hormone Replacement Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral micronized progesterone.

Clinical therapeutics, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.